Ten largest shareholders as of June 30, 2026
NameClass A-sharesClass B-sharesShare capital %Votes %
ANNWALL & ROTHSCHILD INVESTMENT AB453 283721 3518,7229,94
NORTHERN TRUST COMPANY1 697 86312,609,67
SIX SIS AG W8IMY1 539 65711,438,77
FJÄRDE AP-FONDEN1 344 0009,987,66
ÅLANDSBANKEN ABP456 5813,392,60
AVANZA PENSION399 6062,972,28
DANGOOR, DAVID370 4552,752,11
P.R BANQUE PIXTET & CIE SA321 1692,381,83
IBKR FINANCIAL SERVICES AG265 9661,971,52
NORDNET PENSIONSFÖRSÄKRING AB237 0451,761,35
Sum 10 largest shareholders453 2837 353 69357,9567,73
Other shareholders5 664 44442,0532,27
Total453,28313,018,137100100
Source: Euroclear Sweden AB
The total registered share capital of Infant Bacterial Therapeutics AB consists of 453,283 class A shares with 10 votes per share and 13,018,137 class B shares with one vote per share, in total 13,471,420 shares.